Assignee
MEDIVIR AB
SE·91 granted patents·29 pending applications·920 citations·filing 1988–2024
Top patents by PatentIndex Score
120 records- 0197US9828408B2HCV polymerase inhibitorsMEDIVIR AB·Filed 2016·Granted Nov 28, 2017·53 cites·11 claims
- 0296US9540411B2HCV polymerase inhibitorsMEDIVIR AB·Filed 2016·Granted Jan 10, 2017·43 cites·17 claims
- 0396US9481703B2HCV polymerase inhibitorsMEDIVIR AB·Filed 2015·Granted Nov 1, 2016·44 cites·23 claims
- 0494US7666856B2Antiviral nucleosidesMEDIVIR AB·Filed 2007·Granted Feb 23, 2010·36 cites·37 claims
- 0593US11447511B2Dioxolane analogues of uridine for the treatment of cancerMEDIVIR AB·Filed 2020·Granted Sep 20, 2022·2 cites·11 claims
- 0692US7601702B2Dutpase InhibitorsMEDIVIR AB·Filed 2005·Granted Oct 13, 2009·28 cites·22 claims
- 0791US7608590B2HCV NS-3 serine protease inhibitorsMEDIVIR AB·Filed 2005·Granted Oct 27, 2009·23 cites·47 claims
- 0890US7700552B2Macrocyclic inhibitors of hepatitis C virusMEDIVIR AB·Filed 2006·Granted Apr 20, 2010·18 cites·12 claims
- 0990US7671032B2HCV NS-3 serine protease inhibitorsMEDIVIR AB·Filed 2005·Granted Mar 2, 2010·18 cites·57 claims
- 1089US10654877B2Dioxolane analogues of uridine for the treatment of cancerMEDIVIR AB·Filed 2019·Granted May 19, 2020·2 cites·12 claims
- 1189US10596220B2SMAC mimeticMEDIVIR AB·Filed 2019·Granted Mar 24, 2020·3 cites·13 claims
- 1288US10144750B2Dioxolane analogues of cytidine for the treatment of cancerMEDIVIR AB·Filed 2015·Granted Dec 4, 2018·6 cites·9 claims
- 1387US7825238B2Antiviral methods employing double esters of 2′, 3′-dideoxy-3′-fluoroguanosineMEDIVIR AB·Filed 2006·Granted Nov 2, 2010·5 cites·8 claims
- 1487US7071173B2Antiviral methods employing double esters of 2′, 3′-dideoxy-3′-fluoroguanosineMEDIVIR AB·Filed 2005·Granted Jul 4, 2006·5 cites·8 claims
- 1586US11351221B2SMAC mimeticMEDIVIR AB·Filed 2020·Granted Jun 7, 2022·1 cites·15 claims
- 1686US9200006B2Protease inhibitorsMEDIVIR AB·Filed 2014·Granted Dec 1, 2015·5 cites·8 claims
- 1786US8735395B2Protease inhibitorsMEDIVIR AB·Filed 2013·Granted May 27, 2014·5 cites·12 claims
- 1886US7893067B2Cysteine protease inhibitorsMEDIVIR AB·Filed 2008·Granted Feb 22, 2011·8 cites·9 claims
- 1986US5576429A5-substituted pyrimidine nucleosides and nucleotidesMEDIVIR AB·Filed 1995·Granted Nov 19, 1996·51 cites·14 claims
- 2085US10336780B2Dioxolane analogues of uridine for the treatment of cancerMEDIVIR AB·Filed 2018·Granted Jul 2, 2019·3 cites·10 claims
- 2185US2023382931A1Dioxolane analogues of uridine for the treatment of cancerMEDIVIR AB·Filed 2023·Application pending·0 cites
- 2284US11951147B2SMAC mimeticMEDIVIR AB·Filed 2022·Granted Apr 9, 2024·0 cites·17 claims
- 2384US10822360B2Dioxolane analogues of uridine for the treatment of cancerMEDIVIR AB·Filed 2020·Granted Nov 3, 2020·1 cites·13 claims
- 2484US5473063ASynthesis of furanosyl compounds useful as intermediates in preparation of nucleoside analoguesMEDIVIR AB·Filed 1991·Granted Dec 5, 1995·34 cites·2 claims
- 2584US5284837ADerivatives of purine, process for their preparation and a pharmaceutical preparationMEDIVIR AB·Filed 1989·Granted Feb 8, 1994·17 cites·15 claims
- 2683US12378209B2Protease inhibitorsMEDIVIR AB·Filed 2022·Granted Aug 5, 2025·0 cites·1 claims
- 2783US10723709B2Protease inhibitorsMEDIVIR AB·Filed 2019·Granted Jul 28, 2020·1 cites·18 claims
- 2883US10456413B2Combination therapy with sorafenib or regorafenib and a phosphoramidate prodrug of troxacitabineMEDIVIR AB·Filed 2017·Granted Oct 29, 2019·2 cites·20 claims
- 2983US6703394B2Acyclic nucleoside derivativesMEDIVIR AB·Filed 2002·Granted Mar 9, 2004·12 cites·12 claims
- 3083US6458772B1ProdrugsMEDIVIR AB·Filed 1999·Granted Oct 1, 2002·53 cites·12 claims
- 3183US5714503ACompounds and methods for inhibition of HIV and related virusesMEDIVIR AB·Filed 1995·Granted Feb 3, 1998·27 cites·16 claims
- 3283US5593993AMethod for inhibition of HIV related virusesMEDIVIR AB·Filed 1995·Granted Jan 14, 1997·62 cites·9 claims
- 3382US7189849B2Synthesis of acyclic nucleoside derivativesMEDIVIR AB·Filed 2005·Granted Mar 13, 2007·6 cites·14 claims
- 3481US7825239B2Antiviral nucleosidesMEDIVIR AB·Filed 2010·Granted Nov 2, 2010·6 cites·1 claims
- 3581US2023117570A1Dioxolane analogues of uridine for the treatment of cancerMEDIVIR AB·Filed 2022·Application pending·0 cites
- 3681US2023190696A1Pharmaceutical Formulation for Histone Deacetylase InhibitorsMEDIVIR AB·Filed 2023·Application pending·0 cites
- 3779US7795270B2DUTPase inhibitorsMEDIVIR AB·Filed 2005·Granted Sep 14, 2010·3 cites·13 claims
- 3877US5446029AAnti-retroviral activity of 2',3'-dideoxy-3'-fluoronucleosidesMEDIVIR AB·Filed 1993·Granted Aug 29, 1995·42 cites·3 claims
- 3976US12303521B2Methods for treating liver cancers using an orally administered dioxolane nucleotide in combination with an anti-PD1 or anti-PDL1 monoclonal antibodyMEDIVIR AB·Filed 2020·Granted May 20, 2025·1 cites·18 claims
- 4076US6337324B1Pharmaceutical combinationMEDIVIR AB·Filed 1996·Granted Jan 8, 2002·43 cites·36 claims
- 4175US7935681B2Antiviral nucleosidesMEDIVIR AB·Filed 2010·Granted May 3, 2011·2 cites·4 claims
- 4275US5215971AAntiviral pharmaceutical composition comprising 5-substituted pyrimidine nucleosidesMEDIVIR AB·Filed 1991·Granted Jun 1, 1993·40 cites·15 claims
- 4374US11607399B2Pharmaceutical formulation for histone deacetylase inhibitorsMEDIVIR AB·Filed 2020·Granted Mar 21, 2023·0 cites·19 claims
- 4474US6974802B2Treatment of viral infections using prodrugs of 2′,3-dideoxy,3′-fluoroguanosineMEDIVIR AB·Filed 2001·Granted Dec 13, 2005·4 cites·13 claims
- 4574US5849769AN-arylalkyl-N-heteroarylurea and guandine compounds and methods of treating HIV infectionMEDIVIR AB·Filed 1994·Granted Dec 15, 1998·36 cites·37 claims
- 4673US12479870B2Base-modified cytidine nucleotides for leukemia therapyMEDIVIR AB·Filed 2024·Granted Nov 25, 2025·0 cites·17 claims
- 4773US11312693B2Protease inhibitorsMEDIVIR AB·Filed 2020·Granted Apr 26, 2022·0 cites·3 claims
- 4872US10960017B2Sorafenib or regorafenib troxacitabine phosphoramidate prodrug combination therapy for liver cancerMEDIVIR AB·Filed 2019·Granted Mar 30, 2021·1 cites·15 claims
- 4972US5440040APyrimidine intermediatesMEDIVIR AB·Filed 1989·Granted Aug 8, 1995·13 cites·2 claims
- 5072US2010075924A1Dutpase inhibitorsMEDIVIR AB·Filed 2009·Application pending·0 cites
Showing the top 50 of 120 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →